Author pages are created from data sourced from our academic publisher partnerships and public sources.
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and…
BACKGROUND Continuous infusion of levodopa-carbidopa intestinal gel (LCIG) can effectively manage motor and non-motor complications in advanced Parkinson's disease (PD). Healthcare costs, quality of… Expand
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
- Jack Burks, T. Marshall, Xiao-lan Ye
- ClinicoEconomics and outcomes research : CEOR
- 28 April 2017
Purpose To evaluate adherence to disease-modifying therapies (DMTs) among patients with multiple sclerosis (MS) initiating oral and injectable DMTs, and to estimate the impact of adherence on… Expand
Impact of patient selection criteria and treatment history on comparisons of alternative therapies: a case study of atypical antipsychotics.
BACKGROUND Comparative effectiveness analyses using retrospective databases may be highly sensitive to common design decisions employed by researchers. OBJECTIVE To test the sensitivity of… Expand
Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US
BackgroundMultiple sclerosis (MS) is a chronic progressive condition affecting the central nervous system. Progression of MS results in increased level of disability and most patients will eventually… Expand
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson’s disease
Abstract Background: Parkinson’s disease (PD) is an incurable, progressive neurological condition, with symptoms impacting movement, walking, and posture that eventually become severely disabling.… Expand
Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
Background The IMPACT SHPT [Improved Management of Intact Parathyroid Hormone (iPTH) with Paricalcitol-Centered Therapy Versus Cinacalcet Therapy with Low-Dose Vitamin D in Hemodialysis Patients with… Expand
Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis.
- C. Taneja, R. Antaya, A. Berger, T. Marshall, R. Seifeldin, G. Oster
- Journal of drugs in dermatology : JDD
- 1 April 2010
BACKGROUND Tacrolimus 0.1% and pimecrolimus 1.0% are used for short-term and noncontinuous treatment of atopic dermatitis (AD) in patients unresponsive to conventional therapies. OBJECTIVE To… Expand
Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
BackgroundThe IMPACT SHPT [Improved Management of Intact Parathyroid Hormone (iPTH) with Paricalcitol-Centered Therapy Versus Cinacalcet Therapy with Low-Dose Vitamin D in Hemodialysis Patients with… Expand
Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease.
- T. Marshall, Amy Pugh, Angelyn O. Fairchild, S. Hass
- Value in health : the journal of the…
- 1 December 2017
BACKGROUND Effective treatment for advanced Parkinson disease (PD) uncontrolled with oral medication includes device-aided therapies such as deep brain stimulation (DBS) and continuous… Expand
Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients
- A. Sharma, M. Ketteler, T. Marshall, S. Khan, G. Schumock
- Journal of medical economics
- 8 July 2013
Abstract Objective: The objective of this analysis was to compare costs of paricalcitol or cinacalcet plus low dose vitamin D, and of phosphate binders, in patients in the IMPACT SHPT study; and to… Expand